S&P 500   4,957.13 (-1.08%)
DOW   37,869.42 (+0.25%)
QQQ   415.59 (-1.85%)
AAPL   164.79 (-1.35%)
MSFT   399.03 (-1.30%)
META   480.43 (-4.26%)
GOOGL   153.65 (-1.51%)
AMZN   174.04 (-2.89%)
TSLA   147.27 (-1.77%)
NVDA   778.40 (-8.07%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.44 (-2.94%)
CGC   8.03 (+2.55%)
DIS   112.25 (-0.16%)
AMC   3.17 (+8.56%)
PFE   25.89 (+1.97%)
PYPL   61.86 (-0.39%)
XOM   119.71 (+1.00%)
S&P 500   4,957.13 (-1.08%)
DOW   37,869.42 (+0.25%)
QQQ   415.59 (-1.85%)
AAPL   164.79 (-1.35%)
MSFT   399.03 (-1.30%)
META   480.43 (-4.26%)
GOOGL   153.65 (-1.51%)
AMZN   174.04 (-2.89%)
TSLA   147.27 (-1.77%)
NVDA   778.40 (-8.07%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.44 (-2.94%)
CGC   8.03 (+2.55%)
DIS   112.25 (-0.16%)
AMC   3.17 (+8.56%)
PFE   25.89 (+1.97%)
PYPL   61.86 (-0.39%)
XOM   119.71 (+1.00%)
S&P 500   4,957.13 (-1.08%)
DOW   37,869.42 (+0.25%)
QQQ   415.59 (-1.85%)
AAPL   164.79 (-1.35%)
MSFT   399.03 (-1.30%)
META   480.43 (-4.26%)
GOOGL   153.65 (-1.51%)
AMZN   174.04 (-2.89%)
TSLA   147.27 (-1.77%)
NVDA   778.40 (-8.07%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.44 (-2.94%)
CGC   8.03 (+2.55%)
DIS   112.25 (-0.16%)
AMC   3.17 (+8.56%)
PFE   25.89 (+1.97%)
PYPL   61.86 (-0.39%)
XOM   119.71 (+1.00%)
S&P 500   4,957.13 (-1.08%)
DOW   37,869.42 (+0.25%)
QQQ   415.59 (-1.85%)
AAPL   164.79 (-1.35%)
MSFT   399.03 (-1.30%)
META   480.43 (-4.26%)
GOOGL   153.65 (-1.51%)
AMZN   174.04 (-2.89%)
TSLA   147.27 (-1.77%)
NVDA   778.40 (-8.07%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.44 (-2.94%)
CGC   8.03 (+2.55%)
DIS   112.25 (-0.16%)
AMC   3.17 (+8.56%)
PFE   25.89 (+1.97%)
PYPL   61.86 (-0.39%)
XOM   119.71 (+1.00%)
NYSE:CANO

Cano Health (CANO) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$2.00
$9.31
52-Week Range
N/A
Volume
159,142 shs
Average Volume
423,785 shs
Market Capitalization
$12.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.85

Cano Health MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.67 Rating Score
Upside/​Downside
∞ Upside
$1.85 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.22mentions of Cano Health in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$640,233 Sold Last Quarter
Proj. Earnings Growth
Decreasing
From ($2.01) to ($29.82) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.36 out of 5 stars

Medical Sector

884th out of 918 stocks

Offices & Clinics Of Medical Doctors Industry

6th out of 7 stocks

CANO stock logo

About Cano Health Stock (NYSE:CANO)

Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida.

CANO Stock News Headlines

Cano Health, Inc. (CANOQ)
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
American League East Preview Capsules
Firm Retention Summary: Cano Health
See More Headlines
Receive CANO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cano Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Fax
N/A
Employees
4,365
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.85
High Stock Price Target
$3.75
Low Stock Price Target
$0.80
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
3 Analysts

Profitability

Net Income
$-207,270,000.00
Pretax Margin
-36.27%

Debt

Sales & Book Value

Annual Sales
$2.74 billion
Book Value
$100.28 per share

Miscellaneous

Free Float
4,653,000
Market Cap
$12.39 million
Optionable
Optionable
Beta
0.05
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

CANO Stock Analysis - Frequently Asked Questions

Should I buy or sell Cano Health stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cano Health in the last year. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" CANO shares.
View CANO analyst ratings
or view top-rated stocks.

What is Cano Health's stock price target for 2024?

3 Wall Street research analysts have issued 1-year target prices for Cano Health's shares. Their CANO share price targets range from $0.80 to $3.75. On average, they predict the company's share price to reach $1.85 in the next twelve months.
View analysts price targets for CANO
or view top-rated stocks among Wall Street analysts.

This page (NYSE:CANO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners